ACOR

Acorda Therapeutics

Delisted

ACOR was delisted on the 11th of April, 2024.

29 hedge funds and large institutions have $3.71M invested in Acorda Therapeutics in 2023 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 8 increasing their positions, 11 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
29
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$21K
Puts
$19K
Net Calls
Net Calls Change

Top Buyers

1 +$115K
2 +$9.61K
3 +$7.62K
4
HF
HRT Financial
New York
+$7K
5
TRCT
Tower Research Capital (TRC)
New York
+$3.66K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$1.01M
2
$1.01M
3
$519K
4
$398K
5
$128K
6
$102K
7
$93.6K
8
$82.7K
9
$79.4K
10
$45K
11
$43.8K
12
$39.1K
13
$23.9K
14
$22.9K
15
$19.9K
16
$18.5K
17
$15.9K
18
$9K
19
$8.61K
20
$8.42K
21
$7K
22
$7K
23
$5.61K
24
$3.84K
25
$3.53K